-

The Estée Lauder Companies Increases Ownership in DECIEM

ELC has closed the previously announced deal to expand its investment in the company behind fast-growing skin care brands The Ordinary and NIOD

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) announced today that it has completed the first phase of increasing its ownership in DECIEM Beauty Group Inc. (“DECIEM”), the Canadian-based, vertically integrated, multi-brand company. The Estée Lauder Companies (“ELC”) now owns approximately 76% of DECIEM (up from 29%), and has agreed to purchase the remaining interests after a three-year period at a price that will be determined based on the future performance of DECIEM.

Known as “The Abnormal Beauty Company”, DECIEM is an industry disruptor with a consumer-focused approach. It was founded in 2013 by the late Brandon Truaxe, a visionary who set out to change the beauty industry through authenticity and transparency. He developed the company with creativity and innovation alongside Founder, Pasquale Cusano, and Co-Founder, Nicola Kilner, who is continuing as CEO of DECIEM.

DECIEM’s portfolio currently encompasses six brands, including The Ordinary, an internationally popular skin care brand with impressive community- and referral-driven buzz reflecting a deep connection with its global consumer base of skin care devotees.

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. ELC’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, Tommy Hilfiger, M·A·C, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin Paris, TOM FORD BEAUTY, Smashbox, Ermenegildo Zegna, AERIN, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, BECCA, Too Faced, Dr. Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.

ELC-C
ELC-F

Contacts

Media Relations:
Jill Marvin
jimarvin@estee.com

Investor Relations:
Rainey Mancini
rmancini@estee.com

The Estée Lauder Companies Inc.

NYSE:EL


Contacts

Media Relations:
Jill Marvin
jimarvin@estee.com

Investor Relations:
Rainey Mancini
rmancini@estee.com

More News From The Estée Lauder Companies Inc.

The Estée Lauder Companies to Participate in the Morgan Stanley Luxury Conference

NEW YORK--(BUSINESS WIRE)--Stéphane de La Faverie, President and Chief Executive Officer, and Nadine Graf, President, EMEA, UK&I, and Emerging Markets, of The Estée Lauder Companies Inc. (NYSE: EL) will participate in the Morgan Stanley Luxury Conference 2026 in Paris on Tuesday, May 19, 2026, at 4:00 p.m. CEST. Interested parties can access the live webcast of the fireside chat on Tuesday, May 19th from 4:00 p.m. – 4:45 p.m. CEST at http://www.elcompanies.com/investors. The webcast will be...

The Estée Lauder Companies Reports Fiscal 2026 Third Quarter Results

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) today reported its financial results for the third quarter ended March 31, 2026. “Our third quarter results extend strong year-to-date performance, driven by Beauty Reimagined,” said Stéphane de La Faverie, President and CEO. “In the first nine months of fiscal 2026, organic sales for Fragrance rose double-digits, while three of four regions grew, led by high single-digit growth in Mainland China where we outperformed prestig...

The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to sup...
Back to Newsroom